Clearmind Medicine Inc
CMND0.975USD
+0.005+0.47%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
5.00MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Clearmind Medicine Inc Unternehmen
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Unternehmensinformationen
BörsenkürzelCMND
Name des UnternehmensClearmind Medicine Inc
IPO-datumAug 10, 2021
CEODr. Adi Zuloff-Shani
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeAug 10
Addresse101-1220 West 6Th Avenue
StadtVANCOUVER
BörseNASDAQ Capital Market Consolidated
LandCanada
PostleitzahlV6H 1A5
Telefon16042601566
Websitehttps://www.clearmindmedicine.com/
BörsenkürzelCMND
IPO-datumAug 10, 2021
CEODr. Adi Zuloff-Shani
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Director
Director
12.50K
--
Ms. Hila Kiron-revach
Ms. Hila Kiron-revach
Director
Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Director
Director
12.50K
--
Ms. Hila Kiron-revach
Ms. Hila Kiron-revach
Director
Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Gotham Asset Management, LLC
6.38%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
Other
87.58%
Aktionäre
Aktionäre
Anteil
Gotham Asset Management, LLC
6.38%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
Other
87.58%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
6.38%
Investment Advisor
4.26%
Individual Investor
3.37%
Hedge Fund
0.26%
Other
85.73%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
27
768.21K
14.28%
-538.45K
2025Q1
28
780.42K
14.56%
-476.27K
2024Q4
29
785.22K
17.91%
-399.68K
2024Q3
27
937.11K
23.14%
+595.17K
2024Q2
25
525.49K
14.81%
+343.69K
2024Q1
26
524.19K
16.46%
+392.16K
2023Q4
23
150.91K
8.83%
+103.68K
2023Q3
22
47.49K
21.65%
+21.51K
2023Q2
20
27.10K
18.95%
+488.00
2023Q1
16
24.86K
30.09%
+7.91K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Gotham Asset Management, LLC
343.43K
6.38%
+563.00
+0.16%
Mar 31, 2025
AdvisorShares Investments, LLC
205.93K
3.83%
-15.00K
-6.79%
Jun 30, 2025
Shani (Adi Zuloff)
54.23K
1.01%
+52.57K
+3153.45%
Oct 31, 2024
Weiss (Amitay)
39.83K
0.74%
-15.31K
-27.76%
Dec 01, 2024
Rootenberg (Alan)
24.75K
0.46%
+15.29K
+161.59%
May 13, 2025
Cornerstone Wealth Group, LLC
20.00K
0.37%
--
--
Mar 31, 2025
Two Sigma Investments, LP
13.90K
0.26%
+13.90K
--
Mar 31, 2025
Shachar (Yehonatan Samuel)
12.50K
0.23%
--
--
Dec 01, 2024
Itzhaik (Asaf)
12.50K
0.23%
--
--
Dec 01, 2024
Morgan Stanley Smith Barney LLC
2.56K
0.05%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
AdvisorShares Psychedelics ETF
1.99%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
Anteil1.99%
Fidelity Nasdaq Composite Index ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
Datum
Art
Verhältnis
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
Nov 21, 2023
Merger
30<1
